academic article

• Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials..  Clinical therapeutics.  37:1045-1054. 2015
• Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials..  The American journal of managed care.  20:s296-s305. 2014
• Attainment of diabetes-related quality measures with canagliflozin versus sitagliptin..  The American journal of managed care.  20:s16-s24. 2014